Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of bolus insulin dosing on the t ...

Tandem Diabetes Care, Inc. TNDM recently announced that bolus insulin dosing on the t:slim X2 insulin pump utilizing the t:connect mobile app has been cleared by the FDA. With this approval, the ...

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that t:slim X2 insulin pump users have delivered more than 1 million insulin ...

The FDA has issued a recall for the t:connect app, which connects via Bluetooth to insulin pumps Matt Harbicht/Getty Woman holding a smartphone and an illuminated insulin pump (stock photo) More than ...